Posts by: Magdalena Kegel

Magdalena Kegel

Magdalena is a writer with a passion for bridging the gap between the people performing research, and those who want or need to understand it. She writes about medical science and drug discovery. She holds an MS in Pharmaceutical Bioscience and a PhD — spanning the fields of psychiatry, immunology, and neuropharmacology — from Karolinska Institutet in Sweden.

April 11, 2016April 11, 2016

Prostatic Laser Surgery Methods May One Day Be Better Than TURP, Review Says

News

Prostatic laser surgery is a popular option to transurethral resection of the prostate (TURP) for benign prostatic hyperplasia (BPH), but its range of techniques have varying safety and efficacy profiles. A ... Read more

April 5, 2016April 5, 2016

BPH Treatment to Reduce Nighttime Urination Supported in Study, But Efficacy Not Yet Clear

News

A study, recently presented at the Society of Interventional Radiology’s 2016 Annual Scientific Meeting, suggests that prostatic artery embolization (PAE) in men with benign prostatic hyperplasia (BPH) might reduce the need ... Read more

March 23, 2016March 23, 2016

Hormone-Blocking Drug Reported to Markedly Ease Bleeding in BPH Patients Undergoing TURP

News

Researchers at Tanta University, Egypt, report that goserelin acetate, a drug inducing the luteinising hormone-releasing hormone, reduces blood loss during transurethral resection of the prostate (TURP) in patients with benign ... Read more

March 17, 2016March 17, 2016

Most BPH Patients Receive One Therapy Despite Studies Showing Combo Therapy Appears Superior

News

Despite evidence from randomized controlled trials showing that combination therapy has better efficacy in patients with benign prostatic hyperplasia (BPH), a population-based study found that monotherapy with alpha-blockers or 5alpha-reductase ... Read more

March 16, 2016March 16, 2016

Chromosome Abnormalities in BPH Not Related to Disease, Study Finds

News

A small proportion of men suffering from benign prostatic hyperplasia (BPH) have chromosomal abnormalities, most frequently a loss of the Y chromosome. These changes are, however, likely related to aging, ... Read more

March 10, 2016March 10, 2016

In BPH Patients, Bipolar ‘Button’ Plasma Vaporization of Prostate Appears Superior to Classic TURP

News

Bipolar “button” plasma vaporization of the prostate (BPVP) has better short-term results and is associated with fewer complications than classic transurethral resection of the prostate (TURP) in men with benign ... Read more

March 8, 2016March 8, 2016

UroLift System Now Being Tested in BPH Patients with Median Lobe Obstruction

News

NeoTract announced the enrollment of the first patients in the MedLift U.S. IDE trial investigating the safety and effectiveness of the UroLift System for the treatment of people with benign prostatic hyperplasia (BPH) who ... Read more

March 2, 2016March 2, 2016

Benign Prostatic Hyperplasia Review Looks at Range of Treatment Options Now Available

News

Choices for treating the symptoms of benign prostatic hyperplasia (BPH) have never been so great and, with the needs of BPH patients as varied as the treatments available, there is no ... Read more

February 17, 2016February 17, 2016

Fetal Dioxin Exposure Seen to Increase Risk of LUTS Development in Adult Mice

News

A study published in the journal Toxicological Sciences found that exposure to the common environmental pollutant 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) increased the risk of lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH) in genetically ... Read more

February 15, 2016February 15, 2016

TURP Post-Surgical Agitation Risk Eased by Dexmedetomidine Infusion, Study Finds

News

Dexmedetomidine infusion given during surgery for transurethral resection of the prostate (TURP) substantially decreases both the rate and intensity of emergence agitation — a condition where patients waking up from ... Read more